These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16381402)

  • 1. A success story with chronic hepatitis C.
    Weekley D; Yuen JC
    J Ark Med Soc; 2005 Dec; 102(6):158-9. PubMed ID: 16381402
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of viral hepatitis, present and future.
    Rodés J
    J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
    [No Abstract]   [Full Text] [Related]  

  • 3. Peginterferon and ribavirin for hepatitis C.
    Abramowicz M
    N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
    Knapstein J; Galle PR; Zimmermann T
    Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.
    Taffaro M; Pyrsopoulos N; Cedron H; Cacayorin E; Weppler D; Moon J; Nishida S; Levi D; Kato T; Selvaggi G; Tzakis A; Schiff E
    Dig Dis Sci; 2007 Dec; 52(12):3435-7. PubMed ID: 17431776
    [No Abstract]   [Full Text] [Related]  

  • 6. Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?
    Dusheiko G; Danta M
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):130-1. PubMed ID: 16265150
    [No Abstract]   [Full Text] [Related]  

  • 7. Response-guided therapy: optimizing treatment now and in the future.
    Marcellin P; Rizzetto M
    Antivir Ther; 2008; 13 Suppl 1():1-2. PubMed ID: 18432156
    [No Abstract]   [Full Text] [Related]  

  • 8. Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Aguilar Reina J
    Rev Esp Enferm Dig; 2009 Oct; 101(10):665-70. PubMed ID: 19899934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
    Lopukhova NL
    Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502
    [No Abstract]   [Full Text] [Related]  

  • 10. The dilemma for patients with chronic hepatitis C: treat now or warehouse?
    Alberti A; Colombo M; Craxì A; Rizzetto M
    Dig Liver Dis; 2014 Jan; 46(1):27-9. PubMed ID: 24268949
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C in haemodialysis patients requires more ribavirin.
    Slavenburg S; Drenth JP
    Nephrol Dial Transplant; 2008 Jul; 23(7):2430; author reply 2430-1. PubMed ID: 18400821
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.
    Itose I; Kanto T; Inoue M; Miyazaki M; Miyatake H; Sakakibara M; Yakushijin T; Oze T; Hiramatsu N; Takehara T; Kasahara A; Katayama K; Kato M; Hayashi N
    J Med Virol; 2007 May; 79(5):511-21. PubMed ID: 17385691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferons alpha in the treatment of chronic HCV infections].
    Halota W; Pawłowska M; Andrejczyn M
    Przegl Epidemiol; 2004; 58(3):405-11. PubMed ID: 15730004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of peginterferon alpha-2a combinated with ribavirin in the treatment of rebound patient with chronic hepatitis C: a case report].
    He Q; Li ZY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):794. PubMed ID: 21059303
    [No Abstract]   [Full Text] [Related]  

  • 15. Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.
    Cua IH; Kwan V; Henriquez M; Kench J; George J
    Gut; 2006 Oct; 55(10):1521-2. PubMed ID: 16966706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment strategies of acute and chronic hepatitis C].
    Gładysz A; Inglot M
    Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A step forward in therapy for hepatitis C.
    Hoofnagle JH
    N Engl J Med; 2009 Apr; 360(18):1899-901. PubMed ID: 19403908
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future.
    Cammà C; Petta S
    J Hepatol; 2009 Apr; 50(4):648-51. PubMed ID: 19231012
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy for chronic viral hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 2003 Feb; 128(8):370-4. PubMed ID: 12594622
    [No Abstract]   [Full Text] [Related]  

  • 20. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH; Seeff LB
    N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.